Presenting Companies

 
News Articles for Presenting Companies top ^
Bristol-Myers Squibb Company (NYSE:BMY) announced today that 16 abstracts for Orencia were accepted for presentation at the 2014 annual meeting of the American College of Rheumatology (ACR) taking place from November 14-19, 2014 in Boston, MA.
Sign-up for Bristol-Myers Squibb to Present Sixteen Orencia (abatacept) Data Abstracts at The American College of Rheumatology (ACR) 2014 Annual Meeting investment picks
Cutrale / Safra's Misleading Statements and Flawed Calculations Fail to Make the Case that their Contingent $13 Per Share Proposal is Adequate CHARLOTTE, N.C., Sept.
Sign-up for Chiquita Sends Letter to Shareholders and Files Investor Presentation to Set Record Straight on Proposed Combination With Fyffes investment picks
2014/11/19
EPIX Presents Road To The NHL Winter Classic™ and EPIX Presents Road To The NHL Stadium Series™ , a two-part original series from premium TV network EPIX and the National Hockey League, will bring U.S. viewers onto the ice and behind-the-scenes with the Chicago Blackhawks and Washington Capitals as they prepare to compete in the 2015 Bridgestone NHL Winter Classic®, and the Los Angeles Kings and San Jose Sharks on their road to the 2015 Coors Light NHL Stadium Series™. EPIX Presents Road To The NHL Winter Classic will make its U.S. Television Premiere on EPIX December 16 at 10pm ET/PT, 9CT with four weekly episodes following the Blackhawks and the Capitals through regular season games as they get ready to face off in the 2015 Bridgestone NHL Winter Classic® outdoor game at Nationals Park in Washington, D.C. on New Year’s Day, January 1.
Sign-up for EPIX Teams with National Hockey League for Two-Part, Eight-Episode Series, EPIX Presents Road To The NHL Winter Classic & EPIX Presents Road To The NHL Stadium Series investment picks
New Data from Ongoing Phase 1 AG-221 Trial Accepted for Oral Presentation CAMBRIDGE, Mass., Nov.
Sign-up for Agios Pharmaceuticals to Present Clinical and Preclinical Data at the 2014 American Society of Hematology Annual Meeting investment picks
Cytori Therapeutics' Investor Presentation Now Available for On-Demand Viewing Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation Canada NewsWire NEW YORK and SAN DIEGO , Dec.
Sign-up for Cytori Therapeutics' Investor Presentation Now Available for On-Demand Viewing investment picks
Radius Health Summarizes Recent Presentations regarding its Investigational Drug Abaloparatide at the American Society for Bone and Mineral Research and for its Investigational Drug RAD1901 at the 4 th Annual Brain Metastases Research and Emerging Therapy Conference Investigational Drug Abaloparatide Currently in Phase 3 Clinical Development, Top Line Results Expected in December 2014 WALTHAM, Mass., Sept.
Sign-up for Radius Health to Present at BioCentury NewsMakers in the Biotech Industry Conference investment picks
Combination of TG-1101, the Company's Novel Glycoenginereed Anti-CD20 Monoclonal Antibody and TGR-1202, the Company's Once Daily PI3K Delta Inhibitor to be Highlighted in Oral Presentation Updates on the Combination of TG-1101 Plus Ibrutinib, and Single-Agent TGR-1202 to be Featured in Poster Presentations TG Therapeutics to Host a Reception on Monday December 8 th from 7:45 pm – 9:00 pm with Presentations by Leading Clinical Investigators NEW YORK, Nov.
Sign-up for TG Therapeutics, Inc. Announces Data Presentations at the Upcoming 56th American Society of Hematology Annual Meeting investment picks
PharMerica Corporation (NYSE: PMC), a national provider of institutional pharmacy, specialty home infusion, and oncology pharmacy services, today announced that David Froesel, Executive Vice President, Chief Financial Officer and Treasurer, will make a presentation regarding the Company at the Credit Suisse 2014 Healthcare Conference in Phoenix, Arizona, on Tuesday, November 11, 2014, at 1:30 p.m. Mountain Time (3:30 p.m. Eastern Time). The Company also announced that a live broadcast of its conference presentation, as well as any written materials accompanying the presentation, will be available on the “For Investors” tab of the Company’s website, www.pharmerica.com , under “Webcasts and Presentations.” In addition, the webcast, transcript and written materials will be archived on the Company’s website following the event.
Sign-up for PharMerica to Present at the Credit Suisse 2014 Healthcare Conference investment picks
2014/12/9
IAMGOLD Corporation's Presentation Now Available for On-Demand viewing at VirtualInvestorConferences.com Canada NewsWire Company invites individual and institutional investors to log-on to VirtualInvestorConferences.com to view presentations NEW YORK , Dec.
Sign-up for IAMGOLD Corporation's Presentation Now Available for On-Demand viewing at VirtualInvestorConferences.com investment picks
2014/12/9
Organovo Holdings, Inc.'s Presentations Now Available for On-Demand Viewing at VirtualInvestorConferences.com Canada NewsWire Company invites individual and institutional investors to log-on to VirtualInvestorConferences.com to view presentations NEW YORK , Dec.
Sign-up for Organovo Holdings, Inc.'s Presentations Now Available for On-Demand Viewing at VirtualInvestorConferences.com investment picks
--Phase 3 ONTIME Trial Data Selected for Oral Presentation--
Sign-up for Onconova Announces Ten Presentations at the 2014 ASH Annual Meeting investment picks
2014/11/3
Subhead of release should read: Presentation to be Webcast Live at 1:00 p.m. ET on November 11 (instead of Presentation to be Webcast Live at 12:00 p.m. ET on November 11). Second paragraph, first sentence of release should read: The Company’s presentation will be webcast live at 1:00 p.m. ET on Tuesday, November 11.
Sign-up for CORRECTING and REPLACING CIRCOR International to Present at Baird’s 2014 Industrial Conference investment picks
Pfizer Inc. announced today that it will present data for several of its marketed and investigational medicines for inflammatory and immunological conditions at the American College of Rheumatology (ACR) / Association of Rheumatology Health Professionals (ARHP) 2014 Annual Meeting (November 14-19, Boston, Massachusetts). Twenty-one abstracts for XELJANZ ® (tofacitinib citrate) will be presented, including the six-year safety and efficacy analyses from long-term extension (LTE) studies and a summary of real-world patient experience, additional post-hoc analyses from the clinical development program, and health and economics outcomes research, adding to the substantial body of evidence for XELJANZ as an oral treatment option for moderate to severe rheumatoid arthritis (RA). Data will also be presented for several additional Pfizer assets, including PF-04236921, an investigational
Sign-up for Pfizer Highlights Leadership in Rheumatology and Inflammation with Data to be Presented at the ACR/ARHP 2014 Annual Meeting investment picks
Demandware ®, Inc. (NYSE:DWRE), the industry-leading provider of enterprise cloud commerce solutions, today announced that the company will present at the following conferences: Barclays Global Technology Conference Tom Ebling, Demandware Chief Executive Officer, will present on Tuesday, December 9 th at 9:20 a.m. PST at The Palace Hotel, San Francisco, CA BMO Capital Markets 2014 Technology & Digital Media Conference Tim Adams, Demandware Chief Financial Officer, will present on Wednesday, December 10 th at 9:00 a.m. EST at The Grand Hyatt New York, New York An audio webcast of the presentations will be available on Demandware’s investor relations website at http://investors.demandware.com .
Sign-up for Demandware Executives to Present at Upcoming Investor Conferences investment picks
Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that in November and December, data will be presented for the first time investigating the use of KEYTRUDA ® (pembrolizumab) – the company’s anti-PD-1 therapy – in advanced melanoma in comparison to chemotherapy, and in relapsed/refractory classical Hodgkin Lymphoma (cHL) as well as advanced triple negative breast cancer (TNBC). These studies will be presented in oral sessions at the Society for Melanoma Research (SMR) 2014 International Congress, Nov.
Sign-up for New Studies Investigating the Use of KEYTRUDA® (pembrolizumab), Merck’s Anti-PD-1 Therapy, in Advanced Melanoma Compared to Chemotherapy, in Classical Hodgkin Lymphoma and in Triple Negative Breast Cancer, to be Presented for the First Time investment picks
bluebird bio, Inc. (Nasdaq: BLUE) a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases, today announced that data from its ongoing Phase 1/2 HGB-205 and Northstar Studies of LentiGlobin BB305 Drug Product will be presented at the 56th Annual Meeting of the American Society of Hematology (ASH) taking place December 6 – 9, 2014 in San Francisco, California.
Sign-up for bluebird bio to Present LentiGlobin Clinical Data at the American Society of Hematology Conference investment picks
Intevac, Inc. (Nasdaq: IVAC) announced today that company management is scheduled to participate in the following investor event: Needham Next-Gen Storage / Networking Conference Le Parker Meridien Hotel, New York, NY Date: Tuesday, November 11th, 2014 Presentation time: 9:00am EST The presentation webcast and slides will be available through the presentations link on the investor page of the company’s website for a limited time.
Sign-up for Intevac to Present at the Needham Next-Gen Storage and Networking Conference investment picks
Capstead Mortgage Corporation Presentation Now Available for On-Demand Viewing Canada NewsWire Company invites individual and institutional investors as well as advisors to log-on to RetailInvestorConferences.com to view presentation NEW YORK , Nov.
Sign-up for Capstead Mortgage Corporation Presentation Now Available for On-Demand Viewing investment picks
Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast Company invites individual and institutional investors as well as advisors to attend and ask questions at VirtualInvestorConferences.com Canada NewsWire NEW YORK and SAN DIEGO , Nov.
Sign-up for Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast investment picks

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Presenting Companies
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Presented Results  |  Next: Preserve Assets